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Geranylgeranyl transferase (GGTase) is an enzyme involved in the prenylation of many proteins, 
including Ras proteins. Prenylation is the addition of a hydrophobic hydrocarbon chain to a 
molecule. This addition is responsible for the activation of signaling pathways connected to cell 
growth and development. A malfunction of prenylated Ras proteins can lead to uncontrollable 
cell growth and proliferation which can lead to many types of diseases, including cancer. This 
study focuses on the synthesis of a probe that is identical to the GGTase natural substrate, 
geranylgeranyldiphosphate (GGPP), with the only difference being the addition of a norbornene 
motif. This non-natural GGTase substrate will trick the enzyme into binding with the non-natural 
substrate rather than its natural substrate geranylgeranyldiphosphate. The non-natural substrate 
can then be used in conjugation with a modified tetrazine molecule for the selective inhibition of 
GGTase. Norbornenes have shown promise in bioconjugation reactions with modified tetrazines. 
Bioconjugation reactions are reactions which contain desirable features to occur in biological 
settings using reactants that are biologically inert. Future directions include in vitro and in vivo 
tests of the synthesized probe on the inhibition of GGTase.  
Background 
Cell signaling describes how cells relay information to one another. This process has three general 
steps reception, transduction, and cellular response (Figure 1). Reception describes when a 
signaling chemical binds to a receptor protein on the cell membrane. This interaction leads to a 
series of relay molecules passing the signal through the signal transduction pathway known as 
transduction. Finally, the signal leads to a response.15 Geranylgeranyltransferase (GGTase) plays 
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a significant role in regulating cell signaling by causing proteins to become associated with the 
cell membrane, consequently activating them for use in regular cell growth and proliferation. 
This signaling is done by inducing hydrophobicity on proteins containing a CaaX sequence present 
on their C-terminus. A CaaX sequence is representative of a chain of four amino acids in the order 
of cysteine, two aliphatic amino acids, and then any amino acid. This increase in hydrophobicity 
causes membrane association and subsequent activation of downstream processes. 
Geranylgeranyl transferase has shown to have a significant connection to oncogenesis, as well as 
other diseases, through the prenylation of proteins that regulate cell growth and replication. The 
primary function of GGTase is to attach a “membrane anchor”, or a non-polar geranylgeranyl 
group, to proteins in order to make them become membrane associated.1 Further knowledge of 








Figure 1. Cartoon model of cell signaling pathway.15  
GGTase is a member of a group of proteins known as prenyltransferases, which are a family of 
proteins that primarily induce membrane association of other complexes.6 There are three main 
types of prenyltransferases; farnesyltransferase, GGTase, and Rab GGTase.6 Farnesyltransferase 
functions as an enzyme that transfers farnesyl groups to proteins in order to introduce 
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hydrophobicity.6 The natural substrate of farnesyltransferase is farnesyl diphosphate (Figure 2). 
GGTase functions as an enzyme that transfers geranylgeranyl groups to introduce 
hydrophobicity.6 The natural substrate of GGTase is geranylgeranyldiphosphate (Figure 2). 
Farnesyl diphosphate consists of three isoprenoid groups while geranylgeranyl diphosphate 
consists of four isoprenoid groups (or two geranyl groups). 
Finally, Rab GGTase functions as a protein that transfers geranylgeranyl groups more specifically 
to a type of protein known as Rab G protiens.6 Rab GGTases are prevalent in ensuring newly 
synthesized G-protein coupled receptors (GPCRs) are expressed on the cell membrane surface 
for use in cell signaling.16 Farnesyltransferase and GGTase are both CaaX sequence specific, 
meaning they catalyze the activation of proteins with a CaaX box specifically, and serve similar 
functions to prenylate proteins to allow for membrane association.6 The CaaX sequence refers to 
a sequence of amino acids with a cysteine, aliphatic amino acid, aliphatic amino acid, and then 
any amino acid.4 
 
 
Figure 2. Natural substrates for farnesyltransferase and GGTase.  
Research on GGTase is significant as its inhibition could help in reducing oncogenesis.2 If GGTase 
is inhibited prenylation is stopped and cell signaling related to growth and division will not occur. 
This would be especially useful for resolving the effects of mutagenic Ras which is always stuck 




The biochemical composition of GGTase is complex. The GGTase protein is a dimer of two 
subunits; the alpha subunit and the beta subunit.6 The crescent shaped alpha subunit of GGTase 
is made up of alpha helices and is roughly 48 kDa, and the beta subunit of GGTase makes up an 
alpha-alpha barrel.6 GGTase has been tentatively designated as a metalloenzyme as the presence 
of Zn2+ could act as a catalyst for prenylation.5 However, the removal of Zn2+ did not show 
evidence for the irreversible inactivation of GGTase.5 It is thought that the zinc cation could be 
involved in the coordination of the -SH (thiol) group on the cysteine of the CaaX box with 
geranylgeranyl groups (Figure 3).5 Magnesium (II) has also been found within the GGTase enzyme 
and is likely involved catalytically in the coordination of geranylgeranyldiphosphate substrates.5  
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Figure 3. Structure of GGTase I with the alpha subunit (red), beta subunit (blue), and catalytic zinc 
ion (magenta). The GGTase natural substrate GGPP is shown in cyan.8  
Mechanism 
GGTase prenylation of a CaaX-protein using a GGPP substrate forms a prenylated protein and  a 
diphosphate byproduct.4 The active site of GGTase is located within the funnel shaped cavity of 
the alpha-alpha barrel of the beta subunit (Figure 3).6 The inside of this alpha-alpha barrel is 
hydrophobic and rich in aromaticity.6 The hydrophobicity of the beta subunit attracts the 
geranylgeranyldiphosphate substrate and is stabilized by electrostatic interactions within the 
active site.6 The zinc (II) ion that is responsible for catalyzing the reaction is coordinated to the 
beta subunit residues Aspb269, Cysb271, and Hisb321.6 Specificity of both GGTase and protein 
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farnesyltransferase could be due to the presence of Thrb49, Pheb53, and Pheb324 within the 
active site in GGTase, these residues can accommodate the extra fourth isoprenoid group present 
on geranylgeranyldiphosphate (Figure 4).6 
 
Figure 4. Crystal structures of GGTase and farnesyltransferase depicting zinc ion coordination and 
residues present in the active sites. Pink residues are of GGTase with the GGPP substrate in cyan. 
Green residues are of farnesyltransferase with FPP substrate in magenta.6  
 
 
There are three main steps to the GGTase mechanism; prenylation, proteolysis, and carboxyl 
methylation (Figure 5).6 Prenylation refers to the addition of a geranylgeranyl group to the C-
terminal of CaaX-proteins, specifically to the -SH (thiol) group of the cysteine present in the CaaX 
box.4 The CaaX sequence consists of a cysteine, two alliphatic amino acids, and any amino acid 
for the “X” variable, often of which for GGTase is leucine.14 Then, the formed CaaX protein- 
isoprenoid complex becomes attached to the endoplasmic reticulum.6 The next stage of this 
process, proteolysis, refers to the cleavage of the AAX amino acids from the aforementioned 
CaaX box by use of an enzyme known as the Ras converting enzyme (RCE1).6 Finally, in the 
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carboxyl methylation stage of the mechanism, the resulting terminal cysteine becomes 
methylated by a protein known as isoprenylcysteine methyltransferase (Icmt). At this point the 
protein is hydrophobic enough to become associated with the cell membrane but, in some cases, 
the association is relatively unstable. This instability leads to another enzyme 
palmitoyltransferase, which is responsible for a lipid modification to the protein known as 
palmitoylation, to take over.18  Palmitoylation is the addition of a hydrophobic functionality to 
the residual cysteine from the aforementioned CaaX box in the form of palmitate (Figure 6).19 
The addition of the additional hydrophobic chain can allow for a more stable association of 
activated proteins with the cell membrane.  
 
 
Figure 5. Graphic demonstrating GGPP substrate and a protein with a CaaX motif undergoing the 
































An important feature of any enzyme or protein is how the protein is regulated. GGTase regulates 
Ras proteins by allowing them to become membrane associated.6 Naturally, a desire for synthetic 
GGTase inhibitors arises to prevent the out of control cell growth and division that arises with 
Ras protein mutation. GGTase inhibitor GGTI-2418 has been synthesized to inhibit GGTase 
selectively and has entered clinical trials, but with severe side effects.6 GGTI-2418 works as a 
competitive inhibitor with the geranylgeranyldiphosphate substrate for GGTase (Figure 7).6 
Another GGTase inhibitor that has been looked into is GGTI-2154 which has shown to induce 
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breast cancer cell death and tumor regression in H-Ras transgenic mice.6 GGTI-2514 also works 
as a competitive inhibitor with the protein substrate geranylgeranyldiphosphate (Figure 7).6 Both 
of these inhibitors were designed to have a similar structure to a CaaX box motif that might be 
recognized by GGTase in the form of CVIL (Figure 7). In that way, these molecules would inhibit 
GGTase by occupying the enzyme’s active space which would not allow for further activation of 
other proteins. However, the use of inhibitors that effect the ability of prenyltransferases to 
function can lead to decreased activation of other common proteins required for regular cell 







Figure 7. Line structures of potential GGTase inhibitors GGTI-2418 and GGTI-2154 in comparison 
to the CVIL CaaX box motif of GGTase recognized proteins.17 
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Application and System 
Prenyltransferase enzymes are an important area of investigation due to the dramatic effect their 
inhibition could have on cancer cell development. Mutations to the Ras oncogene can induce 
irreversible activation of Ras proteins causing uncontrollable cell division and growth which is 
incredibly significant as roughly 20% of tumors are induced by these Ras mutations.3 N-Ras, H-
Ras, and K-Ras are all examples of Ras protein substrates for prenyltransferases enzymes.6 
However, these Ras proteins are more commonly prenylated by another type of 
prenyltransferase known as protein farnesyltransferase.6 Consequently, in the case of Ras 
protein mutation leading to uncontrollable cell growth and division, one’s first instinct would be 
to inhibit the protein farnesyltransferase in order to prevent further uncontrollable cell growth. 
This method has been noted to work well in the case of H-Ras protein mutations, however with 
the inhibition of farnesyltransferase N-Ras and K-Ras can go on to be prenylated by GGTase.6 
Therefore, a combination of protein farnesyltransferase inhibitor and GGTase inhibitor is needed 
for the total inhibition of Ras protein prenylation.6   
Further study on these prenyltransferases enzymes can also lead to new information on a disease 
known as Progeria. Progeria is a disease that leads to rapid aging and early death and it occurs 
when a point mutation to the LMNA gene leads to the replacement of a cytosine to a thiamine.6 
This point mutation changes the gene to encode for a progerin protein rather than the norm.6 
The progerin protein is a CaaX protein which allows for it to become prenylated by one of the 
prenyltransferases once the prenylated progeria protein become associated to membranes a 






Figure 8. Proposed six step reaction scheme for the synthesis of a nor-O-C15-OPP non-natural  
GGTase substrate. Dotted arrows indicate reaction was not yet completed.  
 
A six-step synthesis of the desired norbornene containing substrate (1-6) was proposed. Three of 
the six proposed reactions were successfully carried out to yield (1-3) as a fully characterized 
intermediate (Figure 8).  
(1-6) is a Possible GGTase Substrate Which Could Allow for Further Enzyme Study 
The natural substrate of GGTase, geranylgeranyldiphosphate (GGPP), has an isoprenoid 
containing structure that is 20 carbons long with a diphosphate functionality along it’s terminus. 
The proposed substrate (1-6) is similar in length and size to the natural substrate GGPP, however 









Figure 9. Line structures depicting the similarities between the natural GGTase substrate, GGPP, 
and the synthesized probe, Nor-O-C15-OPP. Both compounds are similar in shape and size as well 
as take up similar amounts of space.  
 
(1-6) Shows Promise for Bioconjugation with Tetrazine in Biological Systems  
A bioconjugation reaction defines a biologically inert and selective reaction that allows for the 
further study of target proteins and peptides.7 Bioconjugation reactions are typically two-step 
reactions. First, a biomolecule is modified with a biologically inert motif capable of selectively 
reacting with a different biologically inert motif. Next, a reaction is then completed between the 
two motifs . The second motif is designed to have the capability of holding a cargo (Figure 10).7 
The cargo would then be specifically targeted to cells and enzymes of interest rather than being 
administered to undesired cells. These reactions have been useful in protein engineering, 
immunoassay development, cell surface modification, and biolabeling.7 The cargo delivered to 
the target of interest could include fluorescent markers for visualization, or even therapeutics. 
 
The motif utilized in this study is a norbornene for bioconjugation reaction with tetrazine. This 
was chosen for its cost, stability, and commercial availability. Tetrazines have shown to complete 
ligation with other motifs in a bioconjugation reactions. One study shows the significance of non-
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strained alkene-tetrazine cycloaddition to form what is known as a triazoline (Figure 11).11 These 
reactions were promoted by ring strain or light and have been known to be unstable in 
comparison to other cycloaddition reactions.11 The lower stability of triazolines makes them less 
desirable of a bioconjugation reaction as they are likely to be more reactive with other species. 
The oxanorbornadiene has also shown promise in ligation reactions with tetrazine in which it 
undergoes a [3+2] Diels Alder cycloaddition (Figure 11).12 This type of reaction, however, yielded 
rather slow reaction rates at approximately 10-4 M-1s-1.11 The tetrazine ligation with strained 
alkenes however have shown a faster reaction rate (Figure 11). For example, the strained alkene 
trans-cyclooctene reacted with a modified tetrazine with a second order rate constant of roughly 
103 M-1s-1, this is ten million times faster.13  
Norbornenes have been shown to react well with tetrazines due to their balance between strain 
promoted reactivity and their chemical stability.7 Due to these capabilities it is hypothesized that 
the synthesized substrate (1-6) will successfully perform a bioconjugation reaction with tetrazine 
in a biological environment. Tetrazine molecules containing attached cargo can be specifically 
delivered to (1-6) when reacted. This capability could allow for the specific delivery of identifiers, 










Figure 10. Visual representation of biorthogonal reactions. The “warhead” shape is 
representative of the target enzyme substrate with an attached biologically inert motif. 
Bioconjugation occurs with the addition of the chemical labeling reagent with the star shape 

























Figure 11. Triazoline synthesis by non-strained alkene-tetrazine cycloaddition route (a), 










Nor-C15-O-THP Synthetic Route   
The first step of the proposed 6 step synthetic route was used to protect the terminal alcohol 
present on the geraniol starting material. Protection of the terminal alcohol was accomplished 
through the use of a THP group. Oxidation of the protected product (1-1) led to the synthesis of 
many undesired isomers, along with the desired isomer (1-2) (figure 12). This 2,3-sigmatropic 
rearrangement led to the addition of hydroxyl or aldehyde groups at each methyl group present 
on the starting material. There was no way to avoid this but some of the potential side products 
could be reduced through careful reaction monitoring. Purification of the desired isomer (1-2) 
was obtained through column chromatography. The intent of this oxidation reaction was to 
induce more reactivity to the terminal end of the compound for subsequent modifications.  
 
Figure 12. Depiction of possible isomers that could have been synthesized during oxidation 
reaction for the desired (1-2). The desired product in green, a precursor to the desired product 





Subsequent bromination following the oxidation was to promote a single replacement 
mechanism between the terminal bromine and norbornene functional groups in following 
steps. Two synthetic routes were attempted for the bromination leading to the synthesis of (1-
3). The first route included the use of dry ice to cool the N-bromosuccinimide-dimethylsulfide 
solution to temperatures much lower than 0oC for up to an hour before being warmed and re-
cooled. This method also required a much longer reaction time at roughly an hour after the 
addition of (1-2). The second route for the synthesis of (1-3) was as described in the methods 
section where the N-bromosuccinimide-dimethylsulfide was cooled to a temperature of 0oC by 
use of ice and reaction times were significantly shorter at roughly ten minutes after the 
addition of HO-C15-OTHP. The second reaction was favored as higher percent yields were 
achieved, as well as it proved to be a greener synthetic method.  
Characterization of brominated compound (1-3) via 1H-NMR yielded an unexpected splitting 
pattern for the peak at 4.4 ppm (Figure 13). This peak is expected to be representative of the 
CH2 group adjacent to the bromine on (1-3) which should appear as having the splitting pattern 
of a singlet. A possible explanation for the unexpected result could be the presence of a regio-
isomer of the compound where the bromine is present on the methyl group adjacent to its 
desired place (Figure 14). Further analysis is necessary for a more cohesive explanation.  
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Figure 13. 1H-NMR spectra for (1-3) with the unexpected splitting pattern for 𝛼 at 4.4 ppm 








Figure 14. Suggested line structures of the possible regio isomer of brominated intermediate (1-
3) (right) compared to the desired terminal bromide isomer of (1-3) (left).  
 
 
Synthesis of (1-4) included the addition of a norbornene motif. Characterization of (1-4) via 1H-
NMR showed the product synthesized, while it did show signs of the desired product (1-4), was 





GGTase has been shown to activate mutated proteins, such as Ras proteins, leading to 
oncogenesis. Through the proposed 6-step synthesis, (1-6) shows promise for the identification 
and inactivation of GGTase enzymes by synthesizing a non-natural substrate capable of 
biocojugation. Three of the six steps were successfully carried out and characterized. Further 
work for the optimization and completion of the synthesis of the desired product (1-6) is needed. 
After completion of the synthesis, a series of in-vitro and in-vivo tests on the capabilities of this 
molecule to carry out successful bioconjugation reactions with a modified tetrazine will be 
completed.  
Experimental and Methods:  
C15-O-THP (1-1) 
All trans farnesol (15 g, 67.45 mmol), DHP (9.11 ml, 99.83 mmol), and PPTs (1.275 g, 5.059 mmol) 
was combined in dichloromethane (DCM) (100 ml) and stirred at room temperature for 5 hours. 
Reaction progress was monitored by TLC. The reaction mixture was concentrated, diluted with 
ether (30 ml), and washed with brine (3x30 ml). The ether layer was dried with sodium sulfate 
and concentrated to yield 17.468 g C15-O-THP (84.6% yield).  
HO-C15-O-THP (1-2) 
C15-O-THP (10 g, 32.629 mmol), t-BuOOH (4.352 g, 48.291 mmol), SeO2 (0.1195 g, 1.077 mmol), 
and salicylic acid (0.1488 g, 1.077 mmol) were dissolved in DCM (20 ml) stirred overnight. 
Reaction progress was monitored by TLC. The reaction mixture was concentrated, and excess t-
BuOOH was removed by diluting the reaction mixture with toluene (25 ml) and concentrating it 
off. Then, the mixture was diluted with toluene (50 ml) and washed with water (3x80ml) before 
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concentrating off the toluene from the organic layer. Then, the mixture was diluted with ether 
(80 ml) and washed with NaHCO3 (100 ml) before drying the organic layer with Na2SO4. The 
resulting solution was purified with column chromatography in (7:3 hexane:EtoAc) to yield 1.115 
g HO-C15-O-THP (11.15% yield).  
Br-C15-O-THP (1-3) 
N-bromosuccinimide (NBS) (0.703 g, 3.950 mmol) was dissolved in dichloromethane (DCM) (5 ml) 
cooled to below -10oC, and put under N2. Next, dimethylsulfide (DMS) (0.315 g, 5.077 mmol) was 
added and the reaction mixture was stirred for 1 hour. Then the mixture was warmed to 0oC and 
re-cooled to below -10oC. HO-C15-O-THP (1g, 3.103 mmol) was dissolved in DCM (5 ml) and 
stirred for 20 minutes before addition to the reaction solution. Reaction progress was monitored 
through TLC in 3:4 hexane:EtOAc. The reaction was quenched using saturated NaHCO3 (10 ml), 
extracted with EtoAc (3x20 ml), and dried using MgSO4. Residual EtoAc was concentrated off and 
the mixture was purified using column chromatography in (3:4 hexane:EtOAc) to yield 0.136 
grams of Br-C15-O-THP (11.4% yield).  
Nor-C15-O-THP (1-4) 
Norbornene alcohol (0.0383 g, 3.098 x 10-4 mmol) was dissolved in THF (1 mL) at 0OC in a pressure 
tube. Next, 30% NaH dispersion in mineral oil (0.0125 g, 5.21 x 10-4 mmol) was added and the 
solution stirred for 10 minutes to form a white liquid. Brominated isoprenoid (1-3) (0.10 g, 
0.00026 mmol) was added to the solution which subsequently caused the solution to turn a dark 
yellow-orange color. The solution was stirred for 1 week. Reaction progress was monitored 
through TLC conditions. Then, the reaction was quenched with water (20 mL) and washed with 
EtOAc (3x20mL). The product was dried with NaSO4 and concentrated. Residual EtOAc was 
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concentrated off and the mixture was purified using column chromatography (95:5 
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